Lokivetmab

Showing 4 of 4 results
Lokivetmab is a monoclonal antibody used to treat allergic dermatitis and atopic dermatitis in dogs. It targets the cytokine interleukin-31 (IL-31), which plays a key role in itch and inflammation. Read more

Lokivetmab is a monoclonal antibody used to treat allergic dermatitis and atopic dermatitis in dogs. It targets the cytokine interleukin-31 (IL-31), which plays a key role in itch and inflammation.

Essential insights

  • Inhibition of IL-31: Lokivetmab specifically binds to IL-31, preventing its interaction with cell surface receptors. This reduces signaling responsible for itch and inflammation.
  • Reduction of Itch and Inflammation: By neutralizing IL-31, Lokivetmab rapidly alleviates itch and promotes healing of skin damage caused by chronic itching.
  • High Specificity: Lokivetmab is specifically designed to target canine IL-31 with minimal effects on other molecules or processes, reducing the risk of side effects.

Products

Dog icon
Cytopoint (3 - 10 kg)

Cytopoint (3 - 10 kg)

10 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog icon
Cytopoint (10 - 20 kg)

Cytopoint (10 - 20 kg)

20 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog icon
Cytopoint (20 - 30 kg)

Cytopoint (20 - 30 kg)

30 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog icon
Cytopoint (30 - 40 kg)

Cytopoint (30 - 40 kg)

40 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
VETiSearch™ ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - VAT Number: 39926679
VETiSearch.co.uk Copyright © 2026. All rights reserved. VETiSearch contains information on veterinary medicinal products authorised for marketing in the United Kingdom and is intended for veterinary professionals. The information is used at your own risk. VETiSearch disclaims all liability for errors, omissions and lack of updates, as well as for any loss or damage that may arise from the use of the information.